Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 641 - 648 of 11439 results
Bridging Justice Gaps in San Diego
December 6, 2023| Article| Viewpoint
New York Governor Voices Concerns About Proposed Noncompete Ban
December 5, 2023| News
Mintz Bolsters Healthcare Practice With Wiley Partner
December 5, 2023| News
HHS Court Filings Indicate that Agency Intends to Preserve Copay Accumulators
December 4, 2023| Blog| Viewpoint
New York Non-Compete Update: Governor Will Not Sign Non-Compete Bill Unless Changes Are First Made
December 4, 2023| Blog| Viewpoint
Michigan Latest To Have PBMs Get Licenses To Operate In State
December 1, 2023| News
Energy & Sustainability Client Feature — Copernic Catalysts
December 1, 2023| Article| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.